You are here: Annual Meeting / Past Events / 2016 / Programme at a glance
Sunday, 17.12.2017

Program

PRE-MEETING EVENT: WEDNESDAY, April 27th, 2016

13.00-19.00 CINP EDUCATIONAL WORKSHOP

UPDATE ON NEUROPSYCHOPHARMACOLOGY (seats limited to 40)

Brian Leonard (Galway, Ireland)
Gregers Wegener (Aarhus, Denmark)
Halldora Jonsdottir (Reykjavik, Iceland)

THURSDAY, APRIL 28th, 2016

09.00- REGISTRATION OPENS

09.00-10.00 SCNP GENERAL ASSEMBLY (MEMBERS ONLY)

10.00-10.05 SCNP 2016 Opening

President’s Welcome

Gregers Wegener (Aarhus, Denmark)

10.05-10.50 OPENING LECTURE

SCNP 2016 Opening Lecture

Moderator: Gregers Wegener (Aarhus, Denmark)

Efficacy on SSRI. Evidence from Multicenter studies.
Elias Eriksson (Gothenburg, Sweden)

10.50-11.00 STRETCHING LEGS BREAK

11.00-13.00 PLENARY SESSION

Update on new drugs

Moderators: Ole A. Andreassen (Oslo, Norway), Anders Tingström (Lund, Sweden)

Brexpriprazole: a new treatment option in psychosis
Anna-Greta Nylander (Copenhagen, Denmark)

NMDA receptor modulators as possible treatments for CNS disorders
  Torsten Meldgaard Madsen (Chicago, USA)

Lurasidone – a new drug for the treatment of psychosis
Logos Curtis (Geneva, Switzerland)

13.00-13.45 LUNCH

13.45-15.15 SCNP YOUNG SCIENTIST SYMPOSIUM

Moderators: Gregers Wegener (Aarhus, Denmark) & Ole A. Andreassen (Oslo, Norway)

Speakers to be announced (based on competition)

15.15-15.45 COFFEE BREAK

15.45-16.30 SCNP LECTURE

Moderator: Páll Matthíasson (Reykjavik, Iceland)

Magic Mushrooms for depression?
David Nutt (London, United Kingdom)

16.30-17.15 SCNP LECTURE

Moderator: Pall Mathiasson (Reykjavik, Iceland)

Brain imaging applications and potential in psychiatry, uselfullnes for treatment prediction

Phil McGuire (London, UK)

17.15-18.45 POSTER SESSION

Refreshments

19.30- SCNP 2016 Dinner

Dinner with food and wine (at Centralværkstedet, Aarhus, http://www.centralvaerkstedet.dk/ )

 

FRIDAY, APRIL 29th, 2016

09.00-09.45 SCNP LECTURE

Moderator: Anders Tingström (Lund, Sweden)

Rewiring faulty circuits: the role of deep brain stimulation?

Thomas Schlaepfer (Bonn, Germany)

09.45-10.15 COFFEE BREAK

10.15-11.45 PLENARY SESSION

Cardiovascular comorbidity in mental illness and treatment, relationship to psychopharmacology

Moderators: Ole Andreassen (Oslo) & Ingrid Dieset (Oslo)

Impairments in the kynurenine pathway as a shared vulnerability factor for schizophrenia and atherosclerosis

Sophie Erhardt (Stockholm, Sweden)

Update on metabolic side effects of antipsychotics, and evidence based management

Erik Johnsen (Bergen, Norway)

The role of inflammation in cardiovascular and metabolic co-morbidity in psychotic disorders

Ingrid Dieset, (Oslo, Norway)

11.45-13.15 PLENARY SESSION

Recent new updates on ADHD

Moderators: Per Hove Thomsen (Aarhus, Denmark) & Bo Söderpalm (Gpthenburg, Sweden)

Scandinavian Registry based studies: what do they tell us about course of ADHD, and the role of medication

Per Hove Thomsen (Aarhus, Denmark)

Pharmacoloepidemiology of ADHD

Charlotte Skoglund (Sweden)

Prognosis of ADHD following intervention

Berit Bihlar (Stockholm, Sweden)

13.15-14.00 LUNCH

14.00-14.45 SCNP LECTURE

Moderator: Olli Kampman (Tampere, Finland)

Optogenetics & Dreadd: Possible implications for the patients

Anders Tingström (Lund, Sweden)

15.00-15.15 LEG STRETCHING BREAK

15.15-16.45 PLENARY SESSION

New treatment options in affective disorders

Moderators: Anders Tingström (Lund, Sweden) & Gregers Wegener (Aarhus, Denmark)

Smartphone assisted follow-up, treatment and assessment in Bipolar Disorder

Maria Faurholt-Jepsen (Copenhagen, Denmark)

Targeting the endocannabinoid system in depression – an new option for intervention

Sâmia Joca (São Paulo, Brazil)

Bio-behavioral characterization of a selective alpha-2C-receptor antagonist in translational animal models of schizophrenia and depression

Brian Harvey (Potchefstroom, South Africa)

16.45 CONCLUSION OF THE MEETING

 

NOTE: PROGRAM MAY CHANGE WITHOUT NOTICE DUE TO EXTERNAL REASONS